PMV Pharmaceuticals Statistics
Share Statistics
PMV Pharmaceuticals has 51.95M
shares outstanding. The number of shares has increased by 0.95%
in one year.
Shares Outstanding | 51.95M |
Shares Change (YoY) | 0.95% |
Shares Change (QoQ) | 0.36% |
Owned by Institutions (%) | 75.54% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 11 |
FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 840.93K, so 1.62% of the outstanding
shares have been sold short.
Short Interest | 840.93K |
Short % of Shares Out | 1.62% |
Short % of Float | 1.92% |
Short Ratio (days to cover) | 3.47 |
Valuation Ratios
The PE ratio is -1.33 and the forward
PE ratio is -0.49.
PMV Pharmaceuticals's PEG ratio is
0.06.
PE Ratio | -1.33 |
Forward PE | -0.49 |
PS Ratio | 0 |
Forward PS | 0.5 |
PB Ratio | 0.44 |
P/FCF Ratio | -1.5 |
PEG Ratio | 0.06 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for PMV Pharmaceuticals.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.22,
with a Debt / Equity ratio of 0.01.
Current Ratio | 12.22 |
Quick Ratio | 12.22 |
Debt / Equity | 0.01 |
Debt / EBITDA | -0.02 |
Debt / FCF | -0.02 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | $-1,249,127.66 |
Employee Count | 47 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | -16.1M |
Effective Tax Rate | 21.52% |
Stock Price Statistics
The stock price has increased by -47.37% in the
last 52 weeks. The beta is 1.5, so PMV Pharmaceuticals's
price volatility has been higher than the market average.
Beta | 1.5 |
52-Week Price Change | -47.37% |
50-Day Moving Average | 0.97 |
200-Day Moving Average | 1.37 |
Relative Strength Index (RSI) | 49.13 |
Average Volume (20 Days) | 181,971 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -85.45M |
Net Income | -58.71M |
EBITDA | -73.67M |
EBIT | -74.81M |
Earnings Per Share (EPS) | -1.14 |
Full Income Statement Balance Sheet
The company has 40.88M in cash and 1.19M in
debt, giving a net cash position of 39.69M.
Cash & Cash Equivalents | 40.88M |
Total Debt | 1.19M |
Net Cash | 39.69M |
Retained Earnings | -368.71M |
Total Assets | 170.61M |
Working Capital | 153.74M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -51.28M
and capital expenditures -655K, giving a free cash flow of -51.94M.
Operating Cash Flow | -51.28M |
Capital Expenditures | -655K |
Free Cash Flow | -51.94M |
FCF Per Share | -1.01 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |